Adverum Biotechnologies Receives Fast Track Designation for ADVM-022 Gene Therapy for the Treatment of wAMD https://t.co/jISBZTua8s
— Marisa Peer (@PeerMarisa) September 19, 2018
https://platform.twitter.com/widgets.js
from Twitter https://twitter.com/PeerMarisa
September 19, 2018 at 01:23PM